@LabMedDiscovery

LabMed Discovery is a high-quality, peer-reviewed, and open-access English journal of laboratory medicine. Sponsored by Ruijin Hospital and SJTU.

 Shanghai, China
sciencedirect.com/journal/labmed-discovery
Joined July 2024
  • Tweets313
  • Following112
  • Followers20
144Media
LabMed Discovery retweeted
nature
@NatureSep 29
A new Chinese-owned journal has set its sights on rivalling the world’s oldest and most influential academic titles go.nature.com/4e1uihy

Chinese-owned science journal created to rival the best

Nature - Newly launched Vita is part of a broader government plan to give China a bigger say in what counts as high-quality science.

nature.com
3
15
3
84
41,608
LabMed Discovery retweeted
LabMed Discovery@wangivy23627Jul 25
🚀 Publish your research with LabMed Discovery! Looking for a global platform to share your breakthroughs in Laboratory Medicine?sciencedirect.com/journal/la…
🚀 Publish your research with LabMed Discovery! Looking for a global platform to share your breakthroughs in Laboratory Medicine?https://sciencedirect.com/journal/labmed-discovery

ALT 🚀 Publish your research with LabMed Discovery! Looking for a global platform to share your breakthroughs in Laboratory Medicine?https://sciencedirect.com/journal/labmed-discovery

1
1
18
LabMed Discovery retweeted
LabMed Discovery@wangivy23627Jul 26
🔬 The clock is ticking! LMD's Special Issue "AI Application in Laboratory Medicine" is now open for submissions. Guest edited by IFCC leaders Prof. Adeli & Prof. Sergio 📷 Open Access 📷 Fast, rigorous peer review Submit your work today!
1
1
15
LabMed Discovery retweeted
LabMed Discovery@wangivy23627Jul 28
AI in pathology has reached a paradoxical stage. Modern computational pathology models can achieve expert-level performance in diagnosis, prognosis, and biomarker prediction — yet only a limited number have become part of routine clinical workflows. sciencedirect.com/science/ar…
🤖 Made with AI
The biggest challenge for AI in pathology is no longer accuracy. It is adoption. Why do powerful AI models remain research prototypes while clinical implementation remains limited? This review reveals the hidden barriers: 🧬 Data instability 🏥 Workflow mismatch 🔐 Trust and governance gaps A new roadmap is proposed to bridge the gap between AI innovation and real-world clinical value.

ALT The biggest challenge for AI in pathology is no longer accuracy. It is adoption. Why do powerful AI models remain research prototypes while clinical implementation remains limited? This review reveals the hidden barriers: 🧬 Data instability 🏥 Workflow mismatch 🔐 Trust and governance gaps A new roadmap is proposed to bridge the gap between AI innovation and real-world clinical value.

1
1
18
LabMed Discovery retweeted
LabMed Discovery@wangivy23627Jul 28
What you eat may decide how your immune cells fight. 🥑🧬 For decades, diet has been considered a background factor in immunology. A new perspective is changing that view.
🤖 Made with AI
1
2
14
LabMed Discovery retweeted
LabMed Discovery@wangivy23627Jul 28
Sleep shapes brain health: BBB breakdown links sleep disorders to cognitive decline.
1
1
19
LabMed Discovery retweeted
LabMed Discovery@wangivy23627Jul 28
Call for papers
1
1
16
LabMed Discovery retweeted
LabMed Discovery@wangivy23627Aug 13
Join us in Shanghai for the 2026 Guangci Forum—LabMed Discovery Academic Forum! Explore precision testing, intelligent diagnostics, emerging technologies, clinical translation, and scholarly publishing with leading experts. 📅 Sept 15, 2026 📍 Ruijin Hospital 🎟 Free registration
1
1
9
LabMed Discovery retweeted
LabMed Discovery@wangivy23627Aug 15
What can spatial and single-cell omics reveal that bulk profiling misses? This review explores tumor heterogeneity, rare immune states, and emerging biomarkers of immunotherapy response, resistance, and irAEs. 🔗 doi.org/10.1016/j.lmd.2025.1… #CancerResearch #SingleCell #Immunotherapy
1
1
11
LabMed Discovery retweeted
LabMed Discovery@wangivy23627Aug 15
What if delivery—not dose—changes the outcome? In 80 children with ASD, a vitamin D3 nanoemulsion produced greater bioavailability and improvements in selected behavioral and language measures vs marketed D3.Promising signals. Larger trials needed. doi.org/10.1016/j.lmd.2025.1…
🤖 Made with AI
Same dose. Same duration. Different outcomes. In 80 children with ASD, a vitamin D3 nanoemulsion produced greater bioavailability and improvements in selected behavioral and language measures compared with marketed vitamin D3. Congratulations to Prof. Nagwa A. Meguid, Dr. Neveen Hassan Nashaat and colleagues on this promising study. https://doi.org/10.1016/j.lmd.2025.100071 #AutismResearch #Nanomedicine

ALT Same dose. Same duration. Different outcomes. In 80 children with ASD, a vitamin D3 nanoemulsion produced greater bioavailability and improvements in selected behavioral and language measures compared with marketed vitamin D3. Congratulations to Prof. Nagwa A. Meguid, Dr. Neveen Hassan Nashaat and colleagues on this promising study. https://doi.org/10.1016/j.lmd.2025.100071 #AutismResearch #Nanomedicine

1
1
12
LabMed Discovery retweeted
LabMed Discovery@wangivy23627Aug 15
What can spatial and single-cell omics reveal that bulk profiling misses? This review explores tumor heterogeneity, rare immune states, and emerging biomarkers of immunotherapy response, resistance, and irAEs. 🔗 doi.org/10.1016/j.lmd.2025.1… #CancerResearch #SingleCell #Immunotherapy
🤖 Made with AI
1
2
16
LabMed Discovery retweeted
LabMed Discovery@wangivy23627Aug 15
🦴Could a bone-derived hormone help reshape metabolic and neurological care? A new review in #LabMedDiscovery explores undercarboxylated osteocalcin (Glu-OCN)—from emerging biomarker to potential therapeutic target. 🔗 doi.org/10.1016/j.lmd.2025.1… #Biomarkers #Metabolism #Neuroscience
Osteoblast secretes OCN Vitamin K/GGCX → Gla-OCN（bone matrix storage） Bone resorption (acid microenvironment) → bioactive Glu-OCN enters blood Osteoporosis: Wnt/β-catenin pathway, enhance bone mineralization Atherosclerosis:

ALT Osteoblast secretes OCN Vitamin K/GGCX → Gla-OCN（bone matrix storage） Bone resorption (acid microenvironment) → bioactive Glu-OCN enters blood Osteoporosis: Wnt/β-catenin pathway, enhance bone mineralization Atherosclerosis:

1
15
LabMed Discovery retweeted
LabMed Discovery@wangivy23627Aug 15
Can a next-generation skin test strengthen TB detection in children? A Phase III trial in LabMed Discovery found that C-TST achieved 83.0% sensitivity, 100% specificity and no serious adverse events. Read open access doi.org/10.1016/j.lmd.2025.1… #Tuberculosis #Pediatrics #LabMedicine
1
18
LabMed Discovery retweeted
LabMed Discovery@wangivy23627Aug 15
How close are we to a Nipah virus vaccine? In LabMed Discovery, Rengarajan maps 5 leading platforms—subunit, viral vector, VLP, mRNA and DNA—and the safety, clinical-trial and scalability gaps still ahead. Read: doi.org/10.1016/j.lmd.2025.1… #NipahVirus #Vaccines
🤖 Made with AI
1
28
LabMed Discovery retweeted
LabMed Discovery@wangivy23627Aug 15
From glycoprotein subunits to mRNA: which platforms could move Nipah virus vaccines forward? A LabMed Discovery article examines 5 strategies, encouraging animal-model results and the safety, trial, funding and scalability barriers to translation. doi.org/10.1016/j.lmd.2025.1…
🤖 Made with AI
1
17
LabMed Discovery retweeted
LabMed Discovery@wangivy23627Aug 15
🌍 Call for Papers | LabMed Discovery Advancing laboratory medicine. Enabling precision medicine. sciencedirect.com/journal/la… #LabMedDiscovery #CallForPapers #LaboratoryMedicine #PrecisionMedicine
🤖 Made with AI
🌍 Call for Papers | LabMed Discovery How can laboratory innovation transform clinical decision-making and advance precision medicine? LabMed Discovery (LMD) warmly invites researchers, clinicians and laboratory medicine professionals worldwide to submit high-quality original research, reviews, perspectives and editorials. We particularly welcome contributions in: • Clinical diagnostics and laboratory innovation • Biomarker discovery, validation and clinical application • Precision medicine and molecular diagnostics • Translational laboratory science • Omics, artificial intelligence and emerging technologies • Point-of-care testing and next-generation diagnostic platforms Dedicated to connecting laboratory science with clinical practice, LMD provides an international platform for innovative research with meaningful diagnostic and translational value. Share your discoveries. Expand their international visibility. Help shape the future of laboratory medicine. 🔗 Submit your manusc

ALT 🌍 Call for Papers | LabMed Discovery How can laboratory innovation transform clinical decision-making and advance precision medicine? LabMed Discovery (LMD) warmly invites researchers, clinicians and laboratory medicine professionals worldwide to submit high-quality original research, reviews, perspectives and editorials. We particularly welcome contributions in: • Clinical diagnostics and laboratory innovation • Biomarker discovery, validation and clinical application • Precision medicine and molecular diagnostics • Translational laboratory science • Omics, artificial intelligence and emerging technologies • Point-of-care testing and next-generation diagnostic platforms Dedicated to connecting laboratory science with clinical practice, LMD provides an international platform for innovative research with meaningful diagnostic and translational value. Share your discoveries. Expand their international visibility. Help shape the future of laboratory medicine. 🔗 Submit your manusc

1
25
LabMed Discovery retweeted
LabMed Discovery@wangivy23627Aug 15
Why Publish with LabMed Discovery? linkedin.com/pulse/why-publi…

Why Publish with LabMed Discovery?

A Global Call for High-Quality Contributions in Laboratory Medicine and Precision Diagnostics https://www.sciencedirect.

linkedin.com
1
1
14
LabMed Discovery retweeted
LabMed Discovery@wangivy23627Aug 13
Join us in Shanghai for the 2026 Guangci Forum—LabMed Discovery Academic Forum! Explore precision testing, intelligent diagnostics, emerging technologies, clinical translation, and scholarly publishing with leading experts. 📅 Sept 15, 2026 📍 Ruijin Hospital 🎟 Free registration
🤖 Made with AI
1
1
10
LabMed Discovery retweeted
LabMed Discovery@wangivy23627Jul 11
🧬 From bench to bedside—and back again. @LabMedDiscovery Editor-in-Chief Khosrow Adeli introduces our latest issue, exploring how laboratory medicine is becoming the central hub of biomedical discovery. 🔗 doi.org/10.1016/j.lmd.2026.1… #OpenAccess #LabMedicine #Diagnostics #MultiOmics
1
1
19
LabMed Discovery retweeted
LabMed Discovery@wangivy23627Jul 11
🏃‍♂️ Every cell responds to exercise differently. Now we can see how. New in @LabMedDiscovery: You outlines how single-cell & multi-omic approaches are decoding cell-type-specific exercise responses—and paving the way for precision exercise biomarkers. 🔗 doi.org/10.1016/j.lmd.2026.1…
From muscle adaptation to immune regulation to aging: one cell at a time. 🔗 https://doi.org/10.1016/j.lmd.2026.100129 #ExerciseMedicine #SingleCell #PrecisionHealth #Biomarkers #LabMedDiscovery

ALT From muscle adaptation to immune regulation to aging: one cell at a time. 🔗 https://doi.org/10.1016/j.lmd.2026.100129 #ExerciseMedicine #SingleCell #PrecisionHealth #Biomarkers #LabMedDiscovery

1
24
Load more